Mapping large numbers of results may take a few moments.
Search Results
Showing 51 - 100 of 121 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company GEM Tox Labs | Activity: Research and Development | Company Description GEM Tox Labs conducts research focused on the role of MicroRNA molecules in cancer. | Location Greenville |
| |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park |
| |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham |
| |
Company GeneType | Activity: Research and Development | Company Description GeneType develops genetic risk assessment tests to predict an individual's risk of developing chronic disease. | Location Charlotte |
| |
Company Gilead Sciences Inc. (Raleigh) | Activity: Sales and Operations | Company Description Gilead Sciences' Raleigh office houses the company's business services, human resource operations and information technology hub. | Location Raleigh |
| |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary |
| |
Company GRAIL LLC | Activity: Contract Research and Testing | Company Description GRAIL develops novel technologies to detect multiple cancer types early. GRAIL’s RTP site houses laboratories, processing, warehousing and other supportive functions/areas to expand the diagnostic testing capabilities of their early-stage oncology blood test. | Location Durham |
| |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham |
| |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham |
| |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park |
| |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park |
| |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh |
| |
Company Immunaeon (Winston-Salem) | Activity: Research and Development | Company Description Immunaeon provides services to isolate, analyze, and store healthy immune cells for patients for future immunotherapy treatments. | Location Winston-Salem |
| |
Company Immunolight LLC | Activity: Research and Development | Company Description Immunolight develops energy modulating technology to activate immunotherapeutics for the treatment of cancer. | Location Oak Island |
| |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill |
| |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh |
| |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park |
| |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville |
| |
Company Kaio Therapy LLC | Activity: Research and Development | Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. | Location Raleigh |
| |
Company Kincell Bio | Activity: Production and Manufacturing | Company Description Kincell Bio is a contract development and manufacturing organization that offers analytical development, process development, CMC consulting and early stage GMP cell therapy manufacturing. | Location Research Triangle Park |
| |
Company Lamassu Pharma Inc. | Activity: Research and Development | Company Description Lamassu Pharma is developing small molecule therapeutics to treat acute pancreatitis. | Location Durham |
| |
Company Lucerno Dynamics LLC | Activity: Research and Development | Company Description Lucerno Dynamics is commercializing a medical device for quality control, dosimetry, and quality assurance for nuclear medicine. Future applications of the technology include rheumatoid arthritis, immunotherapy, and chemotherapy assessment. | Location Cary |
| |
Company MAA Laboratories Inc. | Activity: Research and Development | Company Description MAA Laboratories develops new drug products by nanoformulating currently marketed drugs with meaningful clinical benefits. The company’s NanoCont technology requires small clinical trials for the new product regulatory approval through 505(b)(2) pathway. | Location Durham |
| |
Company Madera Therapeutics LLC | Activity: Research and Development | Company Description Madera Therapeutics is developing small molecule anti-cancer agents that function via activation of the mitochondrial protease, ClpP. Madera's TR Compounds have direct effects on bulk cancer cells and inhibit cancer stem cell function. | Location Cary |
| |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough |
| |
Company MedKoo Biosciences Inc. | Activity: Sales and Operations | Company Description MedKoo Biosciences supplies biochemical reagents, specializing in small molecule research-used medicines (i.e. non-human-use drugs). | Location Morrisville |
| |
Company Merlon Inc. | Activity: Research and Development | Company Description Merlon develops small-molecule inhibitors for treatment of BRAF-mutated cancers resistant to BRAF and MEK inhibitors. | Location Durham |
| |
Company Metabolon Inc. | Activity: Contract Research and Testing | Company Description Metabolon is advancing the science of metabolomics for the clinic and life sciences research. Its technology and data are used for biomarker discovery, diagnostic test development, and genomics and population health initiatives. | Location Morrisville |
| |
Company Mizar Therapeutics | Activity: Research and Development | Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. | Location Chapel Hill |
| |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro |
| |
Company Mycosynthetix Inc. | Activity: Research and Development | Company Description Mycosynthetix manages a large collection of fungal isolates and discovers novel fungal metabolites for human and animal health and compounds for agricultural applications. | Location Hillsborough |
| |
Company Nelum Corp. | Activity: Research and Development | Company Description Nelum is a clinical-stage biopharmaceutical company developing patented drugs through an in-license process. Nelum´s focus is in oncology and fibrotic indications. | Location Cary |
| |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill |
| |
Company On.Target Molecules Biotech Inc. | Activity: Research and Development | Company Description O.TM Biotech is developing anti-cancer monoclonal antibodies using a novel technology platform to accelerate advancements in cancer therapeutics. | Location Wilmington |
| |
Company OncoTAb Inc. | Activity: Research and Development | Company Description OncoTAb develops a continuum of products from early detection to treatment of epithelial cancers. Current products on the market and under development address unmet needs in the detection and treatment of pancreatic cancer as well as triple negative and metastatic breast cancer. | Location Charlotte |
| |
Company Oncurie Inc. | Activity: Research and Development | Company Description Oncurie is developing a cure for metastatic cancer through the use of novel molecular radionuclide technology. | Location Raleigh |
| |
Company Pathfinder Pharmaceuticals Inc. | Activity: Research and Development | Company Description Pathfinder Pharmaceuticals specializes in early stage drug discovery with a focus on cancer therapy. | Location Durham |
| |
Company PETNET Solutions Inc. (Winston-Salem) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Winston-Salem |
| |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham |
| |
Company Phenogen Sciences Inc. | Activity: Sales and Operations | Company Description Phenogen Sciences provides predictive testing and risk assessment tools that help physicians proactively manage patient health. | Location Charlotte |
| |
Company PhosphoGam Inc. | Activity: Research and Development | Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. | Location Durham |
| |
Company Pinnacle Hill LLC | Activity: Research and Development | Company Description Pinnacle Hill, a joint venture of UNC-Chapel Hill and Deerfield Management, works with faculty to accelerate the development of their research projects to discover and develop new drugs and therapies for unmet needs. | Location Chapel Hill |
| |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham |
| |
Company RedHill Biopharma | Activity: Sales and Operations | Company Description RedHill Biopharma develops and commercializes orally-administered, small-molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer. Its Raleigh site is the company's U.S. commercial headquarters. | Location Tel-Aviv |
| |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh |
| |
Company Resilience (Durham) | Activity: Production and Manufacturing | Company Description Resilience manufactures viral vectors, a component of cell and gene therapies. | Location Durham |
| |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham |